Clinical Trial Update: Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing extended-release buprenorphine to sublingual buprenorphine in rural settings has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Extended-Release Buprenorphine (buprenorphine extended-release formulation)
• Sublingual Buprenorphine (buprenorphine)

Snippet

Sponsor: Yih-Ing Hser | Conditions: Opioid-Related Disorders, Substance-Related Disorders | Phase 3 | Status: COMPLETED